Global Typhoid Vi Polysaccharide Vaccine Market Research Report 2024

Report ID: 1897607 | Published Date: Oct 2024 | No. of Page: 72 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
1 Typhoid Vi Polysaccharide Vaccine Market Overview
    1.1 Product Overview and Scope of Typhoid Vi Polysaccharide Vaccine
    1.2 Typhoid Vi Polysaccharide Vaccine Segment by Type
        1.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Child
        1.2.3 Adult
    1.3 Typhoid Vi Polysaccharide Vaccine Segment by Application
        1.3.1 Global Typhoid Vi Polysaccharide Vaccine Sales Comparison by Application: (2022-2028)
        1.3.2 Government Institution
        1.3.3 Private Sector
        1.3.4 Other
    1.4 Global Typhoid Vi Polysaccharide Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Typhoid Vi Polysaccharide Vaccine Revenue 2017-2028
        1.4.2 Global Typhoid Vi Polysaccharide Vaccine Sales 2017-2028
        1.4.3 Typhoid Vi Polysaccharide Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Typhoid Vi Polysaccharide Vaccine Market Competition by Manufacturers
    2.1 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Typhoid Vi Polysaccharide Vaccine Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Typhoid Vi Polysaccharide Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 Typhoid Vi Polysaccharide Vaccine Market Competitive Situation and Trends
        2.5.1 Typhoid Vi Polysaccharide Vaccine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Typhoid Vi Polysaccharide Vaccine Players Market Share by Revenue
        2.5.3 Global Typhoid Vi Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Typhoid Vi Polysaccharide Vaccine Retrospective Market Scenario by Region
    3.1 Global Typhoid Vi Polysaccharide Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Typhoid Vi Polysaccharide Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
        3.3.1 North America Typhoid Vi Polysaccharide Vaccine Sales by Country
        3.3.2 North America Typhoid Vi Polysaccharide Vaccine Revenue by Country
        3.3.3 the United States
        3.3.4 Canada
    3.4 Europe Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
        3.4.1 Europe Typhoid Vi Polysaccharide Vaccine Sales by Country
        3.4.2 Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 UK
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Region
        3.5.2 Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
        3.6.1 Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country
        3.6.2 Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country
        3.7.2 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Typhoid Vi Polysaccharide Vaccine Historic Market Analysis by Type
    4.1 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
    4.2 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
    4.3 Global Typhoid Vi Polysaccharide Vaccine Price by Type (2017-2022)
5 Global Typhoid Vi Polysaccharide Vaccine Historic Market Analysis by Application
    5.1 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
    5.2 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2017-2022)
    5.3 Global Typhoid Vi Polysaccharide Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Sanofi Pasteur SA
        6.1.1 Sanofi Pasteur SA Corporation Information
        6.1.2 Sanofi Pasteur SA Description and Business Overview
        6.1.3 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolio
        6.1.5 Sanofi Pasteur SA Recent Developments/Updates
    6.2 GSK
        6.2.1 GSK Corporation Information
        6.2.2 GSK Description and Business Overview
        6.2.3 GSK Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 GSK Typhoid Vi Polysaccharide Vaccine Product Portfolio
        6.2.5 GSK Recent Developments/Updates
7 Typhoid Vi Polysaccharide Vaccine Manufacturing Cost Analysis
    7.1 Typhoid Vi Polysaccharide Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Typhoid Vi Polysaccharide Vaccine
    7.4 Typhoid Vi Polysaccharide Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Typhoid Vi Polysaccharide Vaccine Distributors List
    8.3 Typhoid Vi Polysaccharide Vaccine Customers
9 Typhoid Vi Polysaccharide Vaccine Market Dynamics
    9.1 Typhoid Vi Polysaccharide Vaccine Industry Trends
    9.2 Typhoid Vi Polysaccharide Vaccine Market Drivers
    9.3 Typhoid Vi Polysaccharide Vaccine Market Challenges
    9.4 Typhoid Vi Polysaccharide Vaccine Market Restraints
10 Global Market Forecast
    10.1 Typhoid Vi Polysaccharide Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Typhoid Vi Polysaccharide Vaccine by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Typhoid Vi Polysaccharide Vaccine by Type (2023-2028)
    10.2 Typhoid Vi Polysaccharide Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Typhoid Vi Polysaccharide Vaccine by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Typhoid Vi Polysaccharide Vaccine by Application (2023-2028)
    10.3 Typhoid Vi Polysaccharide Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Typhoid Vi Polysaccharide Vaccine by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Typhoid Vi Polysaccharide Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Typhoid Vi Polysaccharide Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Typhoid Vi Polysaccharide Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Typhoid Vi Polysaccharide Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Typhoid Vi Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Typhoid Vi Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Typhoid Vi Polysaccharide Vaccine Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Typhoid Vi Polysaccharide Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Typhoid Vi Polysaccharide Vaccine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Typhoid Vi Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Typhoid Vi Polysaccharide Vaccine as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
    Table 16. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
    Table 17. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
    Table 19. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
    Table 20. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
    Table 21. North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
    Table 23. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
    Table 25. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
    Table 33. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
    Table 39. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
    Table 40. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
    Table 41. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Type (2017-2022)
    Table 43. Global Typhoid Vi Polysaccharide Vaccine Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) by Application (2017-2022)
    Table 45. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
    Table 46. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Application (2017-2022)
    Table 48. Global Typhoid Vi Polysaccharide Vaccine Price by Application (2017-2022) & (USD/Unit)
    Table 49. Sanofi Pasteur SA Corporation Information
    Table 50. Sanofi Pasteur SA Description and Business Overview
    Table 51. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product
    Table 53. Sanofi Pasteur SA Recent Developments/Updates
    Table 54. GSK Corporation Information
    Table 55. GSK Description and Business Overview
    Table 56. GSK Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. GSK Typhoid Vi Polysaccharide Vaccine Product
    Table 58. GSK Recent Developments/Updates
    Table 59. Production Base and Market Concentration Rate of Raw Material
    Table 60. Key Suppliers of Raw Materials
    Table 61. Typhoid Vi Polysaccharide Vaccine Distributors List
    Table 62. Typhoid Vi Polysaccharide Vaccine Customers List
    Table 63. Typhoid Vi Polysaccharide Vaccine Market Trends
    Table 64. Typhoid Vi Polysaccharide Vaccine Market Drivers
    Table 65. Typhoid Vi Polysaccharide Vaccine Market Challenges
    Table 66. Typhoid Vi Polysaccharide Vaccine Market Restraints
    Table 67. Global Typhoid Vi Polysaccharide Vaccine Sales Forecast by Type (2023-2028) & (K Units)
    Table 68. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 69. Global Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 70. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 71. Global Typhoid Vi Polysaccharide Vaccine Sales Forecast by Application (2023-2028) & (K Units)
    Table 72. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 73. Global Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 74. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 75. Global Typhoid Vi Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 76. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share Forecast by Region (2023-2028)
    Table 77. Global Typhoid Vi Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 78. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 79. Research Programs/Design for This Report
    Table 80. Key Data Information from Secondary Sources
    Table 81. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Typhoid Vi Polysaccharide Vaccine
    Figure 2. Global Typhoid Vi Polysaccharide Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Child Product Picture
    Figure 4. Adult Product Picture
    Figure 5. Global Typhoid Vi Polysaccharide Vaccine Market Share by Application in 2021 & 2028
    Figure 6. Government Institution
    Figure 7. Private Sector
    Figure 8. Other
    Figure 9. Global Typhoid Vi Polysaccharide Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Typhoid Vi Polysaccharide Vaccine Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Typhoid Vi Polysaccharide Vaccine Sales (2017-2028) & (K Units)
    Figure 12. Typhoid Vi Polysaccharide Vaccine Sales Share by Manufacturers in 2021
    Figure 13. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Typhoid Vi Polysaccharide Vaccine Players: Market Share by Revenue in 2021
    Figure 15. Typhoid Vi Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
    Figure 17. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region in 2021
    Figure 18. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
    Figure 19. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region in 2021
    Figure 20. the United States Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. UK Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Turkey Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Saudi Arabia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. UAE Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Sales Market Share of Typhoid Vi Polysaccharide Vaccine by Type (2017-2022)
    Figure 43. Manufacturing Cost Structure of Typhoid Vi Polysaccharide Vaccine
    Figure 44. Manufacturing Process Analysis of Typhoid Vi Polysaccharide Vaccine
    Figure 45. Typhoid Vi Polysaccharide Vaccine Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi Pasteur SA
GSK
Frequently Asked Questions
Typhoid Vi Polysaccharide Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Typhoid Vi Polysaccharide Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Typhoid Vi Polysaccharide Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Poliovirus Vaccine

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More